260 related articles for article (PubMed ID: 34634262)
1. Perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia: a systematic review of observational studies and meta-analysis.
Madi JM; Paganella MP; Litvin IE; Viggiano M; Wendland EM; Elias KM; Horowitz NS; Braga A; Berkowitz RS
Am J Obstet Gynecol; 2022 May; 226(5):633-645.e8. PubMed ID: 34634262
[TBL] [Abstract][Full Text] [Related]
2. Gestational trophoblastic neoplasia: a meta-analysis evaluating reproductive and obstetrical outcomes after administration of chemotherapy.
Tranoulis A; Georgiou D; Sayasneh A; Tidy J
Int J Gynecol Cancer; 2019 Jul; 29(6):1021-1031. PubMed ID: 31253638
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy outcomes after chemotherapy for trophoblastic neoplasia.
Garcia MT; Lin LH; Fushida K; Francisco RP; Zugaib M
Rev Assoc Med Bras (1992); 2016 Dec; 62(9):837-842. PubMed ID: 28001257
[TBL] [Abstract][Full Text] [Related]
4. The impact of surgical therapies for inflammatory bowel disease on female fertility.
Lee S; Crowe M; Seow CH; Kotze PG; Kaplan GG; Metcalfe A; Ricciuto A; Benchimol EI; Kuenzig ME
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012711. PubMed ID: 31334846
[TBL] [Abstract][Full Text] [Related]
5. Guideline No. 408: Management of Gestational Trophoblastic Diseases.
Eiriksson L; Dean E; Sebastianelli A; Salvador S; Comeau R; Jang JH; Bouchard-Fortier G; Osborne R; Sauthier P
J Obstet Gynaecol Can; 2021 Jan; 43(1):91-105.e1. PubMed ID: 33384141
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
Wang Q; Fu J; Hu L; Fang F; Xie L; Chen H; He F; Wu T; Lawrie TA
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007289. PubMed ID: 28892119
[TBL] [Abstract][Full Text] [Related]
7. The risk of cardiovascular disease in women after miscarriage, stillbirth, and therapeutic abortion: a protocol for a systematic review and meta-analysis.
Muehlschlegel C; Kyriacou H; Al-Mohammad A; Foster-Davies LA; Simmons-Jones F; Oliver-Williams C
Syst Rev; 2020 Oct; 9(1):234. PubMed ID: 33028393
[TBL] [Abstract][Full Text] [Related]
8. Consolidation chemotherapy in postmolar low-risk gestational trophoblastic neoplasia: a systematic review protocol.
Branco-Silva M; Maesta I; Elias K; Berkowitz RS; Abbade JF; Horowitz NS
BMJ Open; 2022 Feb; 12(2):e059484. PubMed ID: 35210351
[TBL] [Abstract][Full Text] [Related]
9. Maternal and perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia in Brazilian women.
Braga A; Maestá I; Michelin OC; Delmanto LR; Consonni M; Rudge MV; Belfort P
Gynecol Oncol; 2009 Mar; 112(3):568-71. PubMed ID: 19108876
[TBL] [Abstract][Full Text] [Related]
10. Association of previous stillbirth with subsequent perinatal outcomes: a systematic review and meta-analysis of cohort studies.
Deng X; Pan B; Lai H; Sun Q; Lin X; Yang J; Han X; Ge T; Li Q; Ge L; Liu X; Ma N; Wang X; Li D; Yang Y; Yang K
Am J Obstet Gynecol; 2024 Mar; ():. PubMed ID: 38437893
[TBL] [Abstract][Full Text] [Related]
11. Perinatal outcomes in pregnancies complicated by maternal cardiomyopathy: a systematic review and meta-analysis.
Eggleton EJ; McMurrugh KJ; Aiken CE
Am J Obstet Gynecol; 2023 Mar; 228(3):283-291. PubMed ID: 36150520
[TBL] [Abstract][Full Text] [Related]
12. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
13. Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis.
Kaplan YC; Ozsarfati J; Nickel C; Koren G
Br J Clin Pharmacol; 2016 May; 81(5):835-48. PubMed ID: 26700396
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
Fu J; Fang F; Xie L; Chen H; He F; Wu T; Hu L; Lawrie TA
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD007289. PubMed ID: 23076934
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of the efficiency and safety of chemotherapy as a therapeutic method for recurrent or resistant gestational trophoblastic neoplasia: A protocol for systematic review and meta-analysis.
Jiang TY; Ren JJ; Zhang Y; Zhao Y; Feng XL
Medicine (Baltimore); 2021 Jun; 100(24):e26263. PubMed ID: 34128856
[TBL] [Abstract][Full Text] [Related]
16. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis.
Brocklehurst P; French R
Br J Obstet Gynaecol; 1998 Aug; 105(8):836-48. PubMed ID: 9746375
[TBL] [Abstract][Full Text] [Related]
17. Reproductive Outcomes After Gestational Trophoblastic Neoplasia. A Comparison Between Single-Agent and Multiagent Chemotherapy: Retrospective Analysis From the MITO-9 Group.
Cioffi R; Bergamini A; Gadducci A; Cormio G; Giorgione V; Petrone M; Rabaiotti E; Pella F; Candiani M; Mangili G
Int J Gynecol Cancer; 2018 Feb; 28(2):332-337. PubMed ID: 29324534
[TBL] [Abstract][Full Text] [Related]
18. Treatments and outcomes in high-risk gestational trophoblastic neoplasia: A systematic review and meta-analysis.
Albright BB; Ellett T; Knochenhauer HE; Goins EC; Monuszko KA; Kaplan SJ; Previs RA; Moss HA; Havrilesky LJ; Davidson BA
BJOG; 2023 Apr; 130(5):443-453. PubMed ID: 36648416
[TBL] [Abstract][Full Text] [Related]
19. Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study.
Braga A; Paiva G; Ghorani E; Freitas F; Velarde LGC; Kaur B; Unsworth N; Lozano-Kuehne J; Dos Santos Esteves APV; Rezende Filho J; Amim J; Aguiar X; Sarwar N; Elias KM; Horowitz NS; Berkowitz RS; Seckl MJ
Lancet Oncol; 2021 Aug; 22(8):1188-1198. PubMed ID: 34181884
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
